Metraipolis › archive › dc_ff7a73c12f65

CLDN6 Expression Plasticity in Ovarian Cancer: Insights into Therapeutic Optimization for CLDN6-Targeted Immunotherapy — Europe PMC PMID:41628300

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41628300
DOI
10.1158/2767-9764.crc-25-0399
License (as archived)
solo-consultazione
Archived
2026-11-06T08:18:21.157Z
SHA-256 of the archived text
36f0f87c6179e9e2b399087c7a6c6afd00086242c89037526afa669a7b2175d4
Stable URL of this page
https://metraipolis.com/documento/dc_ff7a73c12f65

How to cite

CLDN6 Expression Plasticity in Ovarian Cancer: Insights into Therapeutic Optimization for CLDN6-Targeted Immunotherapy — Europe PMC PMID:41628300 — Europe PMC (en), https://europepmc.org/article/MED/41628300 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff7a73c12f65 (Metraipolis archive dc_ff7a73c12f65, sha256 36f0f87c6179e9e2b399087c7a6c6afd00086242c89037526afa669a7b2175d4)
BibTeX
@misc{dcff7a73c12f65,
  title = {CLDN6 Expression Plasticity in Ovarian Cancer: Insights into Therapeutic Optimization for CLDN6-Targeted Immunotherapy — Europe PMC PMID:41628300},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41628300},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff7a73c12f65; sha256 36f0f87c6179e9e2b399087c7a6c6afd00086242c89037526afa669a7b2175d4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41628300. Agents can read the archived copy with the MCP tool read_document.